Oncolytic Viruses - Genetically Engineering the Future of Cancer Therapy
The ability to genetically engineer oncolytic viruses in order to minimize side effects and improve the selective targeting of tumor cells has opened up novel opportunities for treating cancer. Understanding the mechanisms involved and the complex interaction between the viruses and the immune syste...
Saved in:
| Superior document: | Frontiers Research Topics |
|---|---|
| : | |
| Year of Publication: | 2017 |
| Language: | English |
| Series: | Frontiers Research Topics
|
| Physical Description: | 1 electronic resource (193 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 01603nam-a2200361z--4500 | ||
|---|---|---|---|
| 001 | 993543719004498 | ||
| 005 | 20231214133235.0 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 202102s2017 xx |||||o ||| 0|eng d | ||
| 035 | |a (CKB)4100000002484765 | ||
| 035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/55224 | ||
| 035 | |a (EXLCZ)994100000002484765 | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Benjamin Gesundheit |4 auth | |
| 245 | 1 | 0 | |a Oncolytic Viruses - Genetically Engineering the Future of Cancer Therapy |
| 260 | |b Frontiers Media SA |c 2017 | ||
| 300 | |a 1 electronic resource (193 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Frontiers Research Topics | |
| 520 | |a The ability to genetically engineer oncolytic viruses in order to minimize side effects and improve the selective targeting of tumor cells has opened up novel opportunities for treating cancer. Understanding the mechanisms involved and the complex interaction between the viruses and the immune system will undoubtedly help guide the development of new strategies. Theranostic biomarkers to monitor these therapies in clinical trials serve an important need in this innovative field and demand further research. | ||
| 546 | |a English | ||
| 653 | |a theranostic nanomedicine | ||
| 653 | |a cancer immunotherapy | ||
| 653 | |a oncolytic viruses | ||
| 653 | |a antitumor immunity | ||
| 653 | |a oncoimmunology | ||
| 653 | |a gene expression | ||
| 653 | |a transgenes | ||
| 776 | |z 2-88945-358-8 | ||
| 700 | 1 | |a Joshua P. Rosenzweig |4 auth | |
| 906 | |a BOOK | ||
| ADM | |b 2023-12-15 05:47:27 Europe/Vienna |f system |c marc21 |a 2018-03-10 17:16:05 Europe/Vienna |g false | ||
| AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337428260004498&Force_direct=true |Z 5337428260004498 |b Available |8 5337428260004498 | ||